The cytoplasmic domain of Fas ligand costimulates TCR signals

Journal of Immunology

Volumn 177, Issue 3, 2006, Pages 1481-1491

  Sun, Mingyi ^a   Ames, Kristina T ^a   Suzuki, Ivy ^a   Fink, Pamela J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; FAS LIGAND; GAMMA INTERFERON; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROLINE; PROTEIN KINASE B; PROTEIN SH3; STRESS ACTIVATED PROTEIN KINASE; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NFAT;

ADOLESCENT; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME PHOSPHORYLATION; HUMAN; LIPID RAFT; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION INITIATION;

EID: 33746215283     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.3.1481     Document Type: Article

References (72)

1. Weiss, A., B. Manger, and J. Imboden. 1986. Synergy between the T3/antigen receptor complex and Tp44 in the activation of human T cells. J. Immunol. 137: 819-825.
2. Mueller, D. L. 2000. T cells: a proliferation of costimulatory molecules. Curr. Biol. 10: R227-R230.
3. Frauwirth, K. A., and C. B. Thompson. 2002. Activation and inhibition on lymphocytes by costimulation. J. Clin. Invest. 109: 296-299.
4. Rudd, C. E., and H. Schneider. 2003. Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling. Nat. Rev. Immunol. 3: 544-556.
5. Kane, L. P., J. Lin, and A. Weiss. 2002. It's all Rel-ative: NFκB and CD28 costimulation of T cell activation. Trends Immunol. 23: 413-420.
6. Siegel, R. M., F. K. M. Chan, H. J. Chun, and M. J. Lenardo. 2000. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat. Immunol. 1: 469-474.
7. Croft, M. 2003. Costimulation of T cells by OX40, 4-1BB, and CD27. Cytokine Growth Factor Rev. 14: 265-273.
8. Croft, M. 2003. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? Nat. Rev. Immunol. 3: 609-620.
9. Watts, T. H. 2005. TNF/TNFR family members in costimulation of T cell responses. Annu. Rev. Immunol. 23: 23-68.
10. Croft, M. 2005. The evolving crosstalk between co-stimulatory and co-inhibitory receptors: HVEM-BTLA. Trends Immunol. 26: 292-294.
11. + lymphocytes. J. Immunol. 152: 1523-1531.
12. van Essen, D., H. Kikutaki, and D. Gray. 1995. CD40 ligand-transduced costimulation of T cells in the development of helper function. Nature 378: 620-623.
13. + T cell activation response that results in secretion of immunomodulatory cytokines and apoptosis. J. Exp. Med. 191: 651-660.
14. Pollok, K. E., Y. Kim, J. Hurtado, Z. Zhou, K. K. Kim, and B. S. Kwon. 1994. 4-1BB T-cell antigen binds to mature B cells and macrophages, and costimulates anti-μ-primed splenic B cells. Eur. J. Immunol. 24: 367-374.
15. Salih, H. R., P. A. Kiener, and V. Nussler. 2002. 4-1BB ligand-just another costimulating molecule. Int. J. Clin. Pharmacol. Ther. 40: 348-353.
16. Stuber, E., M. Neurath, D. Calderhead, H. P. Fell, and W. Strober. 1995. Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells. Immunity 2: 507-521.
17. Matsumura, Y., T. Hori, S. Kawamata, A. Imura, and T. Uchiyama. 1999. Intracellular signaling of gp34, the OX40 ligand: induction of c-jun and c-fos mRNA expression through gp34 upon binding of its receptor, OX40. J. Immunol. 163: 3007-3011.
18. Wiley, S. R., R. G. Goodwin, and C. A. Smith. 1996. Reverse signaling via CD30 ligand: J. Immunol. 157: 3635-3639.
19. Lens, S. M., P. Drillenburg, B. F. den Drijver, G. van Schijndel, S. T. Pals, R. A. van Lier, and M. H. van Oers. 1999. Aberrant expression and reverse signalling of CD70 on malignant B cells. Br. J. Haematol. 106: 491-503.
20. Chen, N. J., M. W. Huang, and S. L. Hsieh. 2001. Enhanced secretion of IFNγ by activated TH1 cells occurs via reverse signaling through TNF-related activation-induced cytokine. J. Immunol. 166: 270-276.
21. Tamada, K., K. Shimozaki, A. I. Chapoval, G. Zhu, G. Sica, D. Flies, T. Boone, H. Hsu, Y. X. Fu, S. Nagata, et al. 2000. Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway. Nat. Med. 6: 283-289.
22. Scheu, S., J. Alferink, T. Potzel, W. Barchet, U. Kalinke, and K. Pfeffer. 2002. Targeted disruption of LIGHT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxin β in mesenteric lymph node genesis. J. Exp. Med. 195: 1613-1624.
23. Shi, G., H. Luo, X. Wan, T. W. Salcedo, J. Zhang, and J. Wu. 2002. Mouse T cells receive costimulatory signals from LIGHT, a TNF family member. Blood 100: 3279-3286.
24. Ye, Q., C. C. Fraser, W. Gao, L. Wang, S. J. Busfield, C. Wang, Y. Qiu, A. J. Coyle, J. C. Gutierrez-Ramos, and W. W. Hancock. 2002. Modulation of LIGHT-HVEM costimulation prolongs cardiac allograft survival. J. Exp. Med. 195: 795-800.
25. Eissner, G., S. Kirchner, H. Lindner, W. Kolch, P. Janosch, M. Grell, P. Scheurich, R. Andreesen, and E. Holler. 2000. Reverse signaling through transmembrane TNF confers resistance to lipopolysaccharide in human monocytes and macrophages. J. Immunol. 164: 6193-6198.
26. + T cells. J. Immunol. 166: 130-136.
27. Chou, A. H., H. F. Tsai, L. L. Lin, S. L. Hsieh, P. I. Hsu, and P. N. Hsu. 2001. Enhanced proliferation and increased IFNγ production in T cells by signal transduced through TNF-related apoptosis-inducing ligand. J. Immunol. 167: 1347-1352.
28. Huard, B., P. Schneider, D. Mauri, J. Tschopp, and L. E. French. 2001. T cell costimulation by the TNF ligand BAFF. J. Immunol. 167: 6225-6231.
29. Huard, B., L. Arlettaz, C. Ambrose, V. Kindler, D. Mauri, E. Roosnek, J. Tschopp, P. Schneider, and L. E. French. 2004. BAFF production by antigen-presenting cells provides T cell co-stimulation. Int. Immunol. 16: 467-475.
30. Suzuki, I., and P. J. Fink. 1998. Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand. J. Exp. Med. 187: 123-128.
31. + T cells. Proc. Natl. Acad. Sci. USA 97: 1707-1712.
32. + T cells. J. Immunol. 165: 5537-5543.
33. Boursalian, T. E., and P. J. Fink. 2003. Mutation in Fas ligand impairs maturation of thymocytes bearing moderate affinity T cell receptors. J. Exp. Med. 198: 349-360.
34. Eissner, G., W. Kolch, and P. Scheurich. 2004. Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system. Cytokine Growth Factor Rev. 15: 353-366.
35. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science 267: 1449-1456.
36. Nagata, S., and T. Suda. 1995. Fas and Fas ligand: lpr and gld mutations. Immunol. Today 16: 39-43.
37. Bodmer, J. L., P. Schneider, and J. Tschopp. 2002. The molecular architecture of the TNF superfamily. Trends Biochem. Sci. 27: 19-26.
38. Orlinick, J. R., K. B. Elkon, and M. V. Chao. 1997. Separate domains of the human Fas ligand dictate self-association and receptor binding. J. Biol. Chem. 272: 32221-32229.
39. Watts, A. D., N. H. Hunt, Y. Wanigasekara, G. Bloomfield, D. Wallach, B. D. Roufogalis, and G. Chaudhri. 1999. A casein kinase I motif present in the cytoplasmic domain of members of the tumour necrosis factor ligand family is implicated in "reverse signalling". EMBO J. 18: 2119-2126.
40. Hane, M., B. Lowin, M. Peitsch, K. Becker, and J. Tschopp. 1995. Interaction of peptides derived from the Fas ligand with the Fyn-SH3 domain. FEBS Lett. 373: 265-268.
41. Wenzel, J., R. Sanzenbacher, M. Ghadimi, M. Lewitzky, Q. Zhou, D. R. Kaplan, D. Kabelitz, S. M. Feller, and O. Janssen. 2001. Multiple interactions of the cytosolic polyproline region of the CD95 ligand: hints for the reverse signal transduction capacity of a death factor. FEBS Lett. 509: 255-262.
42. Bossi, G., and G. M. Griffiths. 1999. Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells. Nat. Med. 5: 90-96.
43. Blott, E. J., G. Bossi, R. Clark, M. Zvelebil, and G. M. Griffiths. 2001. Fas ligand is targeted to secretory lysosomes via a proline-rich domain in its cytoplasmic tail. J. Cell Sci. 114: 2405-2416.
44. Xiao, S., U. S. Deshmukh, S. Jodo, T. Koike, R. Sharma, A. Furusaki, S. S. Sung, and S. T. Ju. 2004. Novel negative regulator of expression in Fas ligand (CD178) cytoplasmic tail: evidence for translational regulation and against Fas ligand retention in secretory lysosomes. J. Immunol. 173: 5095-5102.
45. Jodo, S., V. J. Pidiyar, S. Xiao, A. Furusaki, R. Sharma, T. Koike, and S. T. Ju. 2005. Fas ligand (CD178) cytoplasmic tail is a positive regulator of Fas ligand-mediated cytotoxicity. J. Immunol. 174: 4470-4474.
46. Spencer, D. M., T. J. Wandless, S. L. Schreiber, and G. R. Crabtree. 1993. Controlling signal transduction with synthetic ligands. Science 262: 1019-1024.
47. Weiss, A., and, J. B. Imboden. 1987. Cell surface molecules and early events involved in human T lymphocyte activation. Adv. Immunol. 41: 1-38.
48. Gunter, K. C., R. N. Germain, R. A. Kroczek, T. Saito, W. M. Yokoyama, C. Chan, A. Weiss, and E. M. Shevach. 1987. Thy-1-mediated T-cell activation requires co-expression of CD3/Ti complex. Nature 326: 505-507.
49. Watanabe, D., T. Suda, H. Hashimoto, and S. Nagala. 1995. Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders. EMBO J. 14: 12-18.
50. Chu, J. L., P. Ramos, A. Rosendorff, J. Nikolic-Zugic, E. Lacy, A. Matsuzawa, and K. B. Elkon. 1995. Massive upregulation of the Fas ligand in lpr and gld mice: implications for Fas regulation and the graft-versus-host disease-like wasting syndrome. J. Exp. Med. 181: 393-398.
51. Shahinian, A., K. Pfeffer, K. P. Lee, T. M. Kundig, K. Kishihara, A. Wakeham, K. Kawai, P. S. Ohashi, C. B. Thompson, and T. W. Mak. 1993. Differential T cell costimulatory requirements in CD28-deficient mice. Science 261: 609-612.
52. Amara, J. F., T. Clackson, V. M. Rivera, T. Guo, T. Keenan, S. Natesan, R. Pollock, W. Yang, N. L. Courage, D. A. Holt, and M. Gilman. 1997. A versatile synthetic dimerizer for the regulation of protein-protein interactions. Proc. Natl. Acad. Sci. USA 94: 10618-10623.
53. Glasebrook, A. L., and F. W. Fitch. 1979. T-cell lines which cooperate in generation of specific cytolytic activity. Nature 278: 171-173.
54. + T cells. Nat. Med. 4: 1377-1382.
55. Bachmann, M. F., R. M. Zinkernagel, and A. Oxenius. 1998. Immune responses in the absence of costimulation: viruses know the trick. J. Immunol. 161: 5791-5794.
56. Imamura, R., K. Konaka, N. Matsumoto, M. Hasegawa, M. Fukui, N. Mukaida, T. Kinoshita, and T. Suda. 2004. Fas ligand induces cell-autonomous NF-κB activation and interleukin-8 production by a mechanism distinct from that of tumor necrosis factor-α. J. Biol. Chem. 279: 46415-46423.
57. Ramnik, X., T. Brennan, Q. Li, C. McCormack, and B. Seed. 1998. Membrane compartmentation is required for efficient T cell activation. Immunity 8: 723-732.
58. Bromley, S. K., W. R. Burack, K. G. Johnson, K. Somersalo, T. N. Sims, C. Sumen, M. M. Davis, A. S. Shaw, P. M. Allen, and M. L. Dustin. 2001. The immunological synapse. Annu. Rev. Immunol. 19: 375-396.
59. Schwartz, J. C. D., X. Zhang, S. G. Nathenson, and S. C. Almo. 2002. Structural mechanisms of costimulation. Nat. Immunol. 3: 427-434.
60. Xavier, R., and B. Seed. 1999. Membrane compartmentation and the response to antigen. Curr. Opin. Immunol. 11: 265-269.
61. Legler, D. R., O. Micheau, M. A. Doucey, J. Tschopp, and C. Bron. 2003. Recruitment of TNR receptor 1 to lipid rafts is essential for TNFα-mediated NFκB activation. Immunity 18: 655-664.
62. Muppidi, J. R., and R. M. Siegel. 2004. Ligand-independent redistribution of Fas (CD95) into lipid rafts mediates clonotypic T cell death. Nat. Immunol. 5: 182-189.
63. Nachbur, U., D. Kassahn, S. Yousefi, D. F. Legler, and T. Brunner. 2006. Post-transcriptional regulation of Fas (CD95) ligand killing activity by lipid rafts. Blood 107: 2790-2796.
64. Holdorf, A. D., K. H. Lee, W. R. Burack, P. M. Allen, and A. S. Shaw. 2002. Regulation of Lck activity by CD4 and CD28 in the immunological synapse. Nat. Immunol. 3: 259-264.
65. Ghadimi, M. P., R. Sanzenbacher, B. Thiede, J. Wenzel, Q. Jing, M. Plomann, A. Borkhardt, D. Kabelitz, and O. Janssen. 2002. Identification of interaction partners of the cytosolic polyproline region of CD95 ligand (CD 178). FEBS Lett. 519: 50-58.
66. Kane, L. P., and A. Weiss. 2003. The P1-3 kinase/Akt pathway and T cell activation: pleiotropic pathways downstream of PIP3. Immunol. Rev. 192: 7-20.
67. Garcia, P., A. B. De Heredia, T. Bellon, E. Carpio, M. Llano, E. Caparros, P. Aparicio, and M. Lopez-Botet. 2004. Signalling via CD70, a member of the TNF family, regulates T cell functions. J. Leukocyte Biol. 76: 263-270.
68. Koretzky, G. A. 1997. The role of Grb2-associated proteins in T-cell activation. Immunol. Today 18: 401-406.
69. Brenner, B., U. Koppenhoefer, A. Lepple-Wienhues, H. Grassme, C. Muller, C. P. Speer, F. Lang, and E. Gulbins. 1997. The CD40 ligand directly activates T-lymphocytes via tyrosine phosphorylation dependent PKC activation. Biochem. Biophys. Res. Commun. 239: 11-17.
70. Brenner, B., U. Koppenhoefer, H. Grassme, J. Kun, F. Lang, and E. Gulbins. 1997. Evidence for a novel function of the CD40 ligand as a signalling molecule in T-lymphocytes. FEBS Lett. 417: 301-306.
71. Krawczyk, C., and J. M. Penninger. 2001. Molecular motors involved in T cell receptor clusterings. J. Leukocyte Biol. 69: 317-330.
72. Germain, R. N. 2004. An innately interesting decade of research in immunology. Nat. Med. 10: 1307-1320.